ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3,3,Headache,Headaches NEC,Headaches,Nerv,N
3,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
5,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
5,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5,6,Headache,Headaches NEC,Headaches,Nerv,N
5,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
5,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,9,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5,10,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5,11,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
5,12,Right ventricular failure,Right ventricular failures,Heart failures,Card,Y
5,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
7,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
9,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
10,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
11,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
12,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
13,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
14,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
15,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
16,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
16,2,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
17,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
18,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
19,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
20,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
21,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
22,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
23,1,Pulmonary infarction,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
24,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
24,2,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
25,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
26,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
26,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
26,3,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
27,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
28,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
28,3,Oesophageal disorder,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
29,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
29,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
30,2,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
30,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
30,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
31,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
31,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
31,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
32,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
32,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
33,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
33,3,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
34,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
34,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
34,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,4,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
35,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
36,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
36,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
36,3,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
36,4,Right ventricular failure,Right ventricular failures,Heart failures,Card,Y
37,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
37,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
37,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
37,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
37,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
38,2,Headache,Headaches NEC,Headaches,Nerv,N
38,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
39,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
39,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
39,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
41,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
42,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
42,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
42,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
42,4,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
42,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
42,6,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
43,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
44,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
44,2,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
44,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
44,4,Central venous catheter removal,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
44,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
44,6,Device connection issue,Device issues NEC,Device issues,Prod,N
44,7,Device related bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
44,8,Inadequate aseptic technique in use of product,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
44,9,Klebsiella test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
44,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
45,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
45,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
46,1,Heart transplant,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,Y
47,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
47,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
48,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
48,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
48,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
48,6,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
48,7,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
48,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
49,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
49,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
49,5,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
49,6,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
49,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
49,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
49,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
49,10,Right ventricular failure,Right ventricular failures,Heart failures,Card,Y
49,11,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
49,12,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
50,1,Blood gases abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
50,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
50,3,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
50,4,Device leakage,Device issues NEC,Device issues,Prod,N
50,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
51,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
51,3,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
52,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
53,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
53,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
54,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
54,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
54,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
55,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
57,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
58,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
58,3,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
59,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
59,2,Headache,Headaches NEC,Headaches,Nerv,N
59,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
59,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,5,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
60,1,Lung transplant,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
60,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
60,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
60,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
61,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
61,2,Lung transplant,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
62,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
62,2,Life support,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
62,3,Lung transplant,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
63,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
64,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
64,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
64,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
65,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
65,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
65,3,Infusion site haemorrhage,Infusion site reactions,Administration site reactions,Genrl,N
66,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
67,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
67,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
67,5,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
67,6,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
67,7,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,Y
68,1,Donor organ tissue preparation issue,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
68,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
69,1,Lung transplant,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
69,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
71,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
71,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
71,4,Spinal cord ischaemia,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
72,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
72,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
72,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
72,4,Spinal cord ischaemia,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
73,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
74,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
74,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
74,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
74,4,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
74,5,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
75,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
75,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
75,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
75,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
75,5,Spinal cord ischaemia,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
76,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
76,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
76,3,Spinal cord ischaemia,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
77,1,Heart and lung transplant,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
77,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
77,3,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
78,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
78,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
78,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
78,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
79,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
79,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
80,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
80,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
81,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
81,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
82,1,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
83,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
84,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
84,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
84,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
85,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
86,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
87,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
88,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
89,1,Needle track marks,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
90,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Needle track marks,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
92,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
93,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
94,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
94,2,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
94,3,Device leakage,Device issues NEC,Device issues,Prod,N
94,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
94,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
94,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
94,7,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
95,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
95,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
96,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
96,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
96,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
97,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
97,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
